LEVODOPA/CARBIDOPA GenPar 250/25 levodopa 250 mg and carbidopa (as monohydrate) 25 mg tablet blister pack

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

levodopa, Quantity: 250 mg; carbidopa monohydrate, Quantity: 27 mg (Equivalent: carbidopa, Qty 25 mg)

Доступна з:

Arrotex Pharmaceuticals Pty Ltd

Фармацевтична форма:

Tablet, uncoated

Склад:

Excipient Ingredients: magnesium stearate; indigo carmine aluminium lake; microcrystalline cellulose; pregelatinised maize starch; crospovidone

Адміністрація маршрут:

Oral

Одиниць в упаковці:

10 tablets, 100 tablets, 20 tablets

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

LEVODOPA/CARBIDOPA GenPar is indicated for the treatment of Parkinson's disease and syndrome. It is useful in relieving many of the symptoms of parkinsonism, particularly rigidity and bradykinesia. LEVODOPA/CARBIDOPA GenPar frequently is helpful in the management of tremor, dysphagia, sialorrhoea and postural instability associated with Parkinson's disease and syndrome.

Огляд продуктів:

Visual Identification: Round, light blue uncoated tablets with 'C' on one side and '20' on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус Авторизація:

Registered

Дата Авторизація:

2018-01-11